January 19, 2025 - 22:11

Investors brace for a volatile ride as President-elect Donald Trump’s second term gets underway on Monday, bringing the promise of significant policy shifts. Market analysts are closely examining which sectors may emerge as winners and losers under the incoming administration.
Historically, Trump's policies have had a profound impact on various industries, with energy, defense, and financial sectors often benefiting from his administration's initiatives. The anticipated focus on deregulation and tax cuts is expected to give a boost to these areas, attracting investor interest. Conversely, sectors such as technology and healthcare may face headwinds due to potential regulatory changes and shifts in trade policies.
As the new term unfolds, investors are advised to stay alert and agile, ready to adapt their strategies in response to the unfolding political landscape. The uncertainty surrounding Trump's agenda, combined with the ongoing economic recovery, suggests that volatility will be a defining feature of the markets in the coming months.
July 12, 2026 - 04:45
Paramount–Warner Bros. merger could make HBO Max a 'staple'Wall Street is still waiting for the Paramount and Warner Bros. Discovery merger to close, but analysts are already betting on how the combined company will reshape the streaming landscape....
July 11, 2026 - 08:53
$9.5 Billion Focus Financial Network Expands to East Coast with Advisor Jennifer McDonaldMINNEAPOLIS, July 10, 2026 -- Focus Financial Network, a wealth management firm overseeing $9.5 billion in client assets, has expanded its footprint to the East Coast by adding financial advisor...
July 10, 2026 - 21:34
What the housing affordability bill means for buyers and sellersA new bipartisan bill in Congress, the 21st Century ROAD to Housing Act, is aiming to tackle the nation`s affordability crisis head-on. The legislation targets three main pain points: a severe...
July 10, 2026 - 09:43
MindRank Announces $52 Million Series B FinancingMindRank AI Ltd., a clinical-stage biotechnology company based in Hangzhou, China, has announced the completion of a $52 million Series B financing round. The funding was led by a group of...